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Epidermal growth factor receptor (EGFR) signaling controls skin development and homeostasis in
mice and humans, and its deficiency causes severe skin inflammation, which might affect epidermal
stem cell behavior. Here, we describe the inflammation-independent effects of EGFR deficiency dur-
ing skin morphogenesis and in adult hair follicle stem cells. Expression and alternative splicing analysis
of RNA sequencing data from interfollicular epidermis and outer root sheath indicate that EGFR con-
trols genes involved in epidermal differentiation and also in centrosome function, DNA damage, cell
cycle, and apoptosis. Genetic experiments employing p53 deletion in EGFR-deficient epidermis reveal
that EGFR signaling exhibits p53-dependent functions in proliferative epidermal compartments, as
well as p53-independent functions in differentiated hair shaft keratinocytes. Loss of EGFR leads to
absence of LEF1 protein specifically in the innermost epithelial hair layers, resulting in disorganization
ofmedulla cells. Thus, our results uncover important spatial and temporal features of cell-autonomous
EGFR functions in the epidermis.1Institute of Cancer Research,
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Skin morphogenesis is a complex process requiring the spatial and temporal orchestration of distinct molec-
ular signaling pathways to ensure correct development of epidermal lineages such as interfollicular epidermis
(IFE), hair follicles (HF), and sebaceous glands. Initiation of HF development is mainly conducted by b-catenin
and SHH signaling (Huelsken et al., 2001; Blanpain and Fuchs, 2009; Hsu et al., 2014), resulting in formation of
hair placodes between embryonic day (E)15 and E17 (Tumbar, 2012). After the critical step of placode forma-
tion, SHH stimulates proliferation of cells within this structure, which then grow down into the dermis as hair
germs and further develop into hair pegs between E17 and E18 (Hsu et al., 2014). Continuous growth of the
hair peg leads to the formation of a mature HF, which is constituted of highly proliferative progenitor cells,
the so-called matrix, at the bottom. Progeny of the matrix gives rise to the distinct differentiated epithelial
cell layers, which comprise the hair or function in hair guidance (Hsu et al., 2014; Adam et al., 2018). The cell
layers from the outer to innermost layer are outer root sheath (ORS), companion layer, three layers of inner
root sheath (IRS), cuticle, cortex, and medulla. WNT/b-catenin and bone morphogenetic protein (BMP)
signaling were shown to orchestrate hair layer differentiation by temporal layering of signaling effectors
(Adam et al., 2018). Impairment in the formation of solely one layer is sufficient to induce the collapse of the
hair shaft and sustained disruption of hair development (DasGupta and Fuchs, 1999; Kaufman, 2003).
Besides instructive Wnt/b-catenin and BMP signaling pathways, epidermal growth factor receptor (EGFR)
signaling strongly contributes to skin development and homeostasis of mice and humans. Mice completely
lacking EGFR are born with open eyes and display severe skin defects, including a pronounced delay in HF
development (Miettinen et al., 1995; Sibilia and Wagner, 1995; Threadgill et al., 1995). Expression of a
dominant-negative mutant of EGFR in keratinocytes (Murillas et al., 1995) and hair transplantation exper-
iments (Hansen et al., 1997) revealed that EGFR-deficient HFs are able to progress throughmorphogenesis
for about 2 weeks after birth, but then fail to enter catagen. Similarly, humanized EGFR mice (hEGFRKI/KI)
exhibit impaired HF morphogenesis, alterations in morphology and distribution of HFs, and a failure in an-
agen to catagen transition owing to inefficient expression of the hEGFR in the skin (Sibilia et al., 2003). At
postnatal day (P)90, hEGFRKI/KI mice mostly contained degenerated HFs with thin hair cell layers, which
were partly destroyed. Later, studies in conditional knockout mice lacking the EGFR specifically in the
epidermal lineage (Nagao et al., 2012; Lichtenberger et al., 2013; Mascia et al., 2013; Bichsel et al., 2016)
confirmed that loss of EGFR in keratinocytes is sufficient to induce skin differentiation defects, catagen
block, loss of the HF niche, and baldness. Moreover, epidermis-specific EGFR knockout results in severeiScience 15, 243–256, May 31, 2019 ª 2019 The Authors.
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skin inflammation and confers high susceptibility to S. aureus infections. Similar phenotypes have also been
observed in cancer patients receiving anti-EGFR therapies (Lichtenberger et al., 2013; Mascia et al., 2013).
In contrast, mice harboring either the naturally occurring EGFR mutation waved2 (Luetteke et al., 1994) or
the transforming growth factor (TGF)-a mutation waved1 (Crew, 1933; Luetteke et al., 1993) only show a
mild phenotype characterized by wavy hair coat and whiskers but otherwise normal physiology. TGFa
shows specific expression in cells of the IRS (Luetteke et al., 1993), suggesting an important role of
EGFR signaling in the control of epithelial hair layer development and hair shape, whereas EREG and
AREG have been shown to affect sebocyte numbers or sebaceous gland size (Dahlhoff et al., 2014; Li
et al., 2016).
So far it has been poorly investigated how much the skin inflammation developing in the absence of
epidermal EGFR affects the stem cell compartments thus aggravating the resulting phenotypes. Therefore
in this study we employed conditional mouse models allowing us to dissect the cell-autonomous functions
of EGFR signaling in distinct keratinocyte and stem cell compartments independently of the non-cell-
autonomous contribution of inflammation. Our results indicate that EGFR signaling ensures DNA integrity
in proliferative compartments, where accumulation of DNA damage results in TP53-dependent cell death.
Moreover, we demonstrate that EGFR controls transcription factor expression in the innermost epithelial
hair lineages, which is required for hair shaft differentiation.RESULTS
Previous studies have shown that skin-specific genetic ablation of EGFR during murine embryonic devel-
opment causes profound defects of HF morphogenesis, but so far lacked detailed mechanistic analysis.
Developing HFs need to go through several sequential phases to give rise to a mature HF (Figure 1A).
To specifically investigate the function of EGFR signaling during the specification and growth phase of
HF morphogenesis, Egfrfl/fl mice (Natarajan et al., 2007) were crossed with K5Cre transgenic mice to
generate mice lacking the EGFR already during embryonic development in the epidermal lineage (EgfrDep
mice, Figures S1A and S1B; Table S3; Lichtenberger et al., 2013). Time course analysis during the growth,
catagen, and telogen phases of HFs showed that EgfrDepmice present a significant delay in HF growth (Fig-
ures 1B–1D), a catagen block (Figures 1C and 1D), and hair shape alterations (Figure S1C).EGFR Deficiency Does Not Result in Alterations of HF Specification during Morphogenesis
First, we analyzed HF specification at late embryonic time points to investigate whether lack of EGFR may
impair early HF development. Staining for E-Cadherin confirmed correct anterior-to-posterior orientation
of hair pegs as detected by the absence of E-Cadherin expression at the anterior part of the HF (Muller-
Rover et al., 1999; Devenport and Fuchs, 2008) in both control and EgfrDep mice (Figure 1E). Furthermore,
the angle between IFE and HF was mainly similar between control and EgfrDep mice (Figures 1F and 1G).
Despite HF growth differences, we did not find differences in expression of hair follicle stem cell (HFSC) fate
factors in newborn mice: histological stainings for the HF progenitor/stem cell markers P-Cadherin and
LHX2 (Folgueras et al., 2013) (Figure 1H) and the NFATc1-positive or Nephronectin (NPTN)-positive pro-
spective bulge region in HF (Horsley et al., 2008; Fujiwara et al., 2011) (Figures 1I and 1J) showed robust
expression and correct location of those factors in embryonic and newborn skin of EgfrDep mice. These re-
sults demonstrate that EGFR is not required to induce embryonic HFSC specification but exerts its function
on proper HF morphogenesis during the growth phase.EGFR Controls Genes Required for Epidermal Differentiation and DNA Integrity
To uncover the genes involved in EGFR-mediated regulation of the growth of epidermal lineages, RNA
sequencing (RNA-seq) analysis was performed on sorted IFE and ORS cells from postnatal day (P)2
mice. To label ORS cells we crossed EgfrDep with LGR5CreERT2GFP mice to make use of LGR5-driven
GFP expression as an ORS marker (Jaks et al., 2008), whereas IFE cells were defined as SCA-Ihi ITGA6hi cells
(Figures S2A–S2C). The time point P2 was chosen, because at that stage there was still no immune cell infil-
tration in the skin of EgfrDep pups (Figure S2D), but a delay in HF growth was already detectable (Figure 1B).
We observed reduced GFP expression in ORS cells of EgfrDep mice at P2, although the total fraction of
LGR5-expressing cells was similar to control mice (Figures S2E–S2H). RNA-seq analysis showed strong
expression of Egfr, Erbb2, and Erbb3 in IFE and ORS of control mice, whereas there was no expression
of Erbb4. Furthermore, we observed no or only low EGFR ligand expression in the different epidermal
compartments, like low Epgn expression in the IFE, and low Hb-egf in both IFE and ORS (Figure S2I).244 iScience 15, 243–256, May 31, 2019
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Figure 1. EGFR Deficiency Does Not Result in Alterations of HF Specification during Morphogenesis
(A) Schematic time course of HF morphogenesis.
(B) HF morphogenesis staging from control and EgfrDep mice at P1. Bars show analysis of 15–20 follicles per mouse from
n = 3 mice per genotype. Data are represented as meanG SD. p values less than 0.05 were considered significant, with
**p < 0.01, ***p < 0.001 as determined by multiple t test using two-stage linear step-up procedure of Benjamini, Krieger,
and Yekutieli with Q = 1%.
(C) Quantification of HF length from control and EgfrDepmice at indicated time points. Bars show analysis of 15–20 follicles
per mouse from n = 3 mice per genotype. Data are represented as meanG SD. p values less than 0.05 were considered
significant, with ***p < 0.001 as determined by multiple t test using two-stage linear step-up procedure of Benjamini,
Krieger, and Yekutieli with Q = 1%.
(D) Fontana-Masson stainings of back skin sections from control and EgfrDep mice at indicated time points. Scale bars,
50 mm.
(E) Immunofluorescence staining for E-Cadherin (green), K5 (red), and nuclei (blue) from control, and EgfrDep mice at
E18.5. Arrow indicates anterior-to-posterior orientation of skin section. A, anterior; P, posterior.
(F) Immunofluorescence staining for K14 (green) and nuclei (blue) from E18.5 control and EgfrDep mice.
(G) Polar plots of angles between IFE and anterior side of HFs from E18.5 control and EgfrDep mice. Plots show analysis of
8–12 follicles per mouse from n = 3mice per genotype. Data represent the absolute number of HFs measured at indicated
angle ranges.
(H) Immunofluorescence staining for P-Cadherin (green), LHX2 (red), and nuclei (blue) from control and EgfrDep mice
at E18.5.
(I) Immunofluorescence staining for NFATc1 (green) and nuclei (blue) from control and EgfrDep mice at P2.
(J) Immunofluorescence staining for Nephronectin (NPNT, green) and nuclei (blue) from control and EgfrDep mice at P2.
Scale bars, 20 mm unless otherwise stated. See also Figure S1.Analysis of differentially expressed genes between control and EgfrDep mice revealed that loss of EGFR
significantly affects the expression of structural genes (Spink5, Lce1e1, Flg, Sprr1a, Klk7, Gjb4), as well as
of genes regulating cell cycle and apoptosis (Perp, Cep120, Klhdc5, Egr1, Fos) in IFE or ORS cells (Figures
2A–2D; Table S1A).iScience 15, 243–256, May 31, 2019 245
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Figure 2. EGFR Controls a Variety of Genes Required for Epidermal Differentiation and DNA Integrity
(A) Heatmap of significantly deregulated genes in P2 fluorescence-activated cell sorted IFE from control and EgfrDep
mice. Each column represents one mouse.
(B) Heatmap of significantly deregulated genes in P2 fluorescence-activated cell sorted ORS from control and EgfrDep
mice. Each column represents one mouse.
(C) qRT-PCR from randomly chosen target genes identified by RNA-seq from P2 IFE. Bars show data from n = 3–5 mice
per genotype. Data are represented as mean G SD. p values less than 0.05 were considered significant, with *p < 0.05,
**p < 0.01 as determined by Student’s t test.
(D) qRT-PCR from randomly selected target genes identified by RNA-seq from P2 ORS. Bars show data from n = 3–5 mice
per genotype. Data are represented as mean G SD. p values less than 0.05 were considered significant, with *p < 0.05,
**p < 0.01, ***p < 0.001 as determined by Student’s t test.
(E) Bar graph of the top 15 GO terms obtained from alternative splicing analysis from IFE keratinocytes.
(F) Bar graph of the top 15 GO terms obtained from alternative splicing analysis from ORS keratinocytes.
(G) Venn diagram of alternative splicing targets from P2 IFE and ORS cells.
(H) Bar graph of the significantly enriched GO terms obtained from overlapping genes displaying alternatively spliced
exons or junction sites from IFE and ORS keratinocytes.
(I) Pie chart of the ratio of alternatively used exons and junction sites of genes within the GO term ‘‘cell cycle.’’
See also Figure S2 and Tables S1A–S1F.
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EGFR Controls Alternative Splicing, which Regulates Centrosome Function and DNA
Integrity
As the list of differentially expressed genes included a variety of targets that were either already shown to
be directly linked to EGFR signaling, such as Flg (Franzke et al., 2012), or belonged to an expected biolog-
ical process, namely, epidermal development, we focused on novel targets not yet reported to regulate
epidermal integrity in the context of EGFR signaling. One of those target genes was Srsf2 (Figure 2B).
The product of this gene is required for the formation of the earliest ATP-dependent splicing complex
and contributes to constitutive as well as alternative splicing (Graveley and Maniatis, 1998). To functionally
investigate whether lack of EGFR might affect mRNA splicing, we analyzed our RNA-seq datasets for alter-
native exon usage employing JunctionSeq (Hartley and Mullikin, 2016). For both compartments, IFE and
ORS, we detected a high number of alternative transcripts upon comparison of control and EGFR-deficient
keratinocytes. Importantly, these genes group into distinct GO terms like ‘‘intracellular signal transduc-
tion,’’ ‘‘Wnt pathway,’’ ‘‘cell cycle,’’ or ‘‘organelle part’’ (Figures 2E and 2F, Table S1B).
To gain more specific information from the large amount of alternatively used exons and junction sites, we
focused on the 191 (11.5%) affected overlapping genes between IFE and ORS (Figure 2G, Table S1C). GO
term analysis on those overlapping targets elucidated that EGFR is required to control the ‘‘perinuclear
region of cytoplasm,’’ ‘‘cell cycle,’’ and ‘‘death’’ in both IFE and ORS (Figure 2H, Table S1D). Deeper inves-
tigation of the genes belonging to the term ‘‘cell cycle’’ revealed a high number of genes important in
centrosome function and DNA damage repair, e.g., Cntrl, Cep192, Clspn, and Bub1b (Table S1E), and
an almost equal number of differentially used exons and junction sites (Figure 2I, Table S1F).EGFR Regulates Proliferation and Prevents DNA Damage in Epidermal Lineages
As both global gene expression and alternative splicing analysis identified genes involved in cell cycle,
centrosome function, andDNAdamage response we hypothesized that a strong disbalance of cell turnover
or survival and apoptosis could explain the growth delay of EGFR-deficient HFs. In light of previous reports
on an important function of EGFR in promotion of proliferation (Hansen et al., 1997; Bol et al., 1998; Xie
et al., 1999; Kiguchi et al., 2000; Lichtenberger et al., 2010), we functionally tested whether EGFR is required
for regulating the proliferation rate of distinct keratinocyte populations. RNA-seq analysis showed down-
regulation of early growth response 1 (Egr1) in the ORS of EgfrDep mice (Figure 2B). It was previously
demonstrated that Egr1 is a downstream target of ERK signaling and involved in cell growth and prolifer-
ation (Mayer et al., 2009; Tarcic et al., 2011). We confirmed EGR1 protein absence in the ORS (Figure 3A), as
well as strongly reduced phospho-ERK1/2 selectively in ORS cells of EGFR-deficient skin (Figure 3B). In
addition, bromodeoxyuridine (BrdU) pulse-chase experiments showed reduced BrdU incorporation into
EGFR-deficient ORS cells after 24h (Figures 3C and S3A), providing evidence that EGFR signaling in the
ORS is required to induce the ERK signaling cascade, leading to Egr1 induction and cell growth or
proliferation. To address whether absence of EGFR also affects proliferation in the IFE, back skin sections
from various time points (P5, P8, P10) were stained for Ki67 and additionally analyzed by flow cytometry after
a 4h BrdU pulse. Our results show that both numbers of Ki67+ cells and BrdU+ cells are reduced in IFE of
EgfrDepmice when compared with control mice (Figures 3D, 3E, and S3B). These data confirm previous find-
ings (Bol et al., 1998; Xie et al., 1999; Kiguchi et al., 2000; Lichtenberger et al., 2010) and provide more
detailed insights into the important role of EGFR in promoting proliferation of the epidermal lineage.
Detailed depiction of exon usage of Centriolin (Cntrl) (Figure S3C) shows that EGFR-deficient keratinocytes
preferentially skip exons 11, 15, and 16. Exon 11 encodes an alternative 30 UTR and leads to a shorter tran-
script, which is known as a 110-kDa variant of Cntrl termed Cep110. Skipping of the alternative part of exon
11 leads to an increase in full-length transcript, encoding a 270-kDa variant of Cntrl, including a domain
required for centrosome localization (Szebenyi et al., 2007). Exons 15 and 16 contribute to the stathmin
domain of CNTRL, which is involved in regulation of mitotic spindle assembly. Further investigation of
Claspin (Clspn) mRNA shows that EgfrDep mice skip exon 12 (Figure S3D). Claspin is required for cell-cycle
arrest in response to DNA damage via activation of CHK1 (Lee et al., 2003). Interestingly, exon 12 encodes a
protein region involved in forming the CHK1-activating domain (CKAD), suggesting that exon skipping
leads to reduced binding of CLSPN to CHK1 and subsequently to reduced clearance of DNA damage.
To test this hypothesis, we investigated centrosome numbers, DNA damage, and apoptosis. Pericentrin
stainings of primary keratinocytes revealed an increased fraction of EGFR-deficient keratinocytes display-
ing more than two centrosomes (Figures 3F and 3G). Moreover, we observed nuclear fragmentation iniScience 15, 243–256, May 31, 2019 247
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Figure 3. EGFR Controls Cell Proliferation as well as Centrosome Function and DNA Integrity
(A) Immunofluorescence staining for ITGB4 (green), EGR1 (red), and nuclei (blue) from P3 control and EgfrDep mice.
(B) Immunohistochemistry staining for phospho-ERK1/2 from P3 control and EgfrDep mice. Asterisk indicates hair
pigmentation.
(C) Quantification of BrdU+ ORS cells of P2 mice 24h after BrdU pulsing. Bars show analysis of 10 follicles per mouse from
n = 4 mice per genotype. Data are represented as meanG SD. p values less than 0.05 were considered significant, with
***p < 0.001 as determined by Student’s t test.
(D) Quantification of the number of Ki67+ IFE nuclei from frozen back skin sections from control and EgfrDep mice at
indicated time points. MF, microscopic field. Bars show analysis of 6 microscopic fields per mouse from n = 3 mice per
genotype. Data are represented as mean G SD. p values less than 0.05 were considered significant, with **p < 0.01 as
determined by Student’s t test.
(E) Quantification of the number of BrdU+ cells from epidermal cell suspensions analyzed by fluorescence-activated cell
sorting from control and EgfrDep mice at indicated time points. Bars show analysis of n = 3 mice per genotype. Data are
represented as mean G SD. p values less than 0.05 were considered significant, with **p < 0.01 as determined by
Student’s t test.
(F) Immunofluorescence staining for Tubulin (green), Pericentrin (red), and nuclei (blue) from primary keratinocytes
derived from control and EgfrDep mice. Arrows point to centrosomes. Scale bars, 5 mm.
(G) Quantification of the percentage of primary keratinocytes harboring more than two centrosomes. Bars show analysis
of 15 cells per mouse from n = 3 mice per genotype. Data are represented as mean G SD. p values less than 0.05 were
considered significant, with ***p < 0.001 as determined by Student’s t test.
(H) Immunofluorescence staining for F-Actin (green) and nuclei (blue) of primary keratinocytes derived from P8 control
and EgfrDep mice. Arrows highlight nuclear fragments. Scale bars, 5 mm.
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Figure 3. Continued
(I) Immunofluorescence staining for P-Cadherin (green), activated caspase 3 (red), and nuclei (blue) from control and
EgfrDep mice at E18.5, showing IFE (top) and HF (bottom).
(J) Immunofluorescence staining for ITGB4 (green), activated caspase 3 (red), and nuclei (blue) from control and EgfrDep
mice at P10, showing IFE (top) and HF matrix (bottom). Arrow highlights an apopotic cell.
(K) Immunofluorescence staining for gH2AX (green) and nuclei (blue) from control and EgfrDep mice at P10, showing IFE
(upper panel) and HF matrix (lower panel). Arrows highlight spots of DNA damage.
(L) Immunohistochemical staining of TP53 on sections of P10 control and EgfrDep mice, showing HF matrix. Asterisk
indicates hair pigmentation, delineated area marks dermal papilla (DP).
Scale bars, 20 mm unless otherwise stated. See also Figure S3.keratinocytes lacking EGFR (Figure 3H). As both, WT and EgfrDep keratinocyte cultures, were negative for
the differentiation marker K1, we exclude that fragmentation of nuclei might be due to accelerated differ-
entiation of EGFR-deficient keratinocytes (Figure S3E). To analyze whether loss of DNA integrity is accom-
panied by increased cell death, we stained back skin sections for active caspase 3. Apoptotic cells were
detected in the IFE and hair pegs of E18.5 epidermis (Figure 3I) as well as in P10 IFE and matrix of EgfrDep
mice (Figure 3J). Furthermore, staining for the DNA damage marker gH2AX uncovered a high number of
gH2AX foci in skin of EgfrDep mice, but not in control mice (Figure 3K). The presence of DNA damage was
accompanied by stabilization and accumulation of TP53 in nuclei of matrix cells from EgfrDep mice
(Figure 3L). These data demonstrate that absence of EGFR leads to accumulation of DNA damage, which
subsequently induces TP53 stabilization and apoptosis.
Apoptosis in IFE and Matrix Is TP53 Dependent, Whereas Loss of Inner Hair Layers Is TP53
Independent
To investigate whether TP53-induced cell death causes impaired HF development in EgfrDep mice, we
crossed EgfrDep mice with p53fl/fl mice to generate Egfr/p53Dep mice (Figures S4A and S4B). Surprisingly,
Egfr/p53Dep mice presented the same phenotype as EgfrDep mice: skin and hair alterations, reduced
survival, and strong skin inflammation (Figures S4C–S4E). However, deletion of TP53 abolished
apoptosis in IFE and matrix cells in EgfrDep mice at P10 (Figures 4A–4D), suggesting a TP53-dependent
mechanism for cell death in these highly proliferative epidermal compartments. Upon closer investiga-
tion of other epithelial compartments in the epidermal lineage, we also detected apoptotic cells in the
hair shaft of EgfrDep mice, which were, however, not affected by additional TP53 deletion (Figures 4E
and 4F), providing evidence for a TP53-independent apoptotic mechanism in postmitotic cells. We
could also confirm the presence of apoptosis in innermost hair layers, such as medulla cells, by trans-
mission electron microscopy (Figure 4G). To characterize whether apoptosis in the hair shaft affects
the differentiation of epithelial hair layers in mice lacking epidermal EGFR, we stained for hair-layer-spe-
cific keratins in control, EgfrDep mice, and Egfr/p53Dep mice. Both EgfrDep mice and Egfr/p53Dep mice
exhibited onset of hair layer differentiation, but displayed an early loss of those layers (Figure 4H). These
data indicate TP53-dependent cell death in proliferative keratinocytes as well as a TP53-independent
mechanism of apoptosis in the non-proliferative, differentiated cells of the hair shaft upon lack of
EGFR signaling.
EGFR Controls Hair Lineage Transcription Factor Expression
To investigate whether transcription factors involved in hair layer differentiation showed altered expression
upon EGFR deletion, we stained for IRS-specific transcription factor GATA-3, as well as for IRS- and HS-
specific factor LEF1 (Merrill, 2001; Kaufman, 2003; Adam et al., 2018). GATA-3 expression was not different
between control and EgfrDepmice (Figure 5A). However, LEF1 was only found to be expressed in IRS cells of
EgfrDep mice, but not in hair shaft cells (Figure 5B). Staining for trichohyalin AE15, which is present in differ-
entiated IRS andmedulla, revealed lack of properly differentiated medulla cells in EgfrDepmice (Figure 5C).
Based on our results, we propose that EGFR signaling affects spatial layering during HF growth and differ-
entiation (Figures 5D and 5E). First, EGFR promotes cell proliferation and ensures DNA integrity in highly
proliferative epidermal compartments, such as IFE, ORS, and matrix. Upon loss of EGFR in those compart-
ments, accumulation of DNA damage mediates TP53-dependent apoptosis (Figure 5D). Second, EGFR
controls hair-layer-specific transcription factor expression to regulate epithelial hair layer specification
and differentiation. EGFR deficiency leads to absence of proper differentiation cues for hair shaft cells, re-
sulting in TP53-independent loss of the medulla layer (Figure 5E).iScience 15, 243–256, May 31, 2019 249
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Figure 4. Apoptosis in IFE and Matrix Is TP53 Dependent, whereas Loss of Inner Hair Layers Is TP53
Independent
(A) Immunofluorescence staining for ITGB4 (green), activated caspase 3 (red) and nuclei (blue) from control, EgfrDep, and
Egfr/p53Dep mice at P10, showing IFE. Arrow highlights an apoptotic cell.
(B) Quantification of the number of activated caspase 3+ IFE cells from control, EgfrDep, and Egfr/p53Depmice at P10. Bars
show analysis of 10 microscopic fields per mouse from n = 3 mice per genotype. Data are represented as mean G SD.
p values less than 0.05 were considered significant, with *p < 0.05 as determined by Kruskal-Wallis test.
(C) Immunofluorescence staining for ITGB4 Integrin (green), activated caspase 3 (red), and nuclei (blue) from control,
EgfrDep, and Egfr/p53Dep mice at P10, showing HF matrix (Mx). Arrow highlights an apoptotic cell.
(D) Quantification of the number of activated caspase 3+ matrix cells from control, EgfrDep, and Egfr/p53Dep mice at P10.
Bars show analysis of 20–30 hair follicles per mouse from n = 3 mice per genotype. Data are represented as meanG SD.
p values less than 0.05 were considered significant, with *p < 0.05 as determined by Kruskal-Wallis test.
(E) Immunofluorescence staining for ITGB4 (green), activated caspase 3 (red), and nuclei (blue) from control, EgfrDep, and
Egfr/p53Dep mice at P10, showing hair shaft (HS). Arrows highlight apoptotic cells.
(F) Quantification of the number of activated caspase 3+ hair shaft cells from control, EgfrDep, and Egfr/p53Depmice at P10.
Bars show analysis of 20–30 hair follicles per mouse from n = 3 mice per genotype. Data are represented as meanG SD.
p values less than 0.05 were considered significant, with *p < 0.05 as determined by Kruskal-Wallis test.
(G) Transmission electron microscopic image of medulla cells from P14 control and EgfrDep mice. Scale bars, 2 mm.
(H) Immunofluorescence staining for ITGB4 (green), cortex marker K31 (red), and nuclei (blue) from control, EgfrDep, and
Egfr/p53Dep mice at P10 (far left). Immunofluorescence staining for ITGB4 (green), IRS (Henle layer) marker K71 (red), and
nuclei (blue) from control, EgfrDep, and Egfr/p53Dep mice at P10 (middle left). Immunofluorescence staining for ITGB4
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Figure 4. Continued
(green), cuticle marker K82 (red), and nuclei (blue) from control, EgfrDep, and Egfr/p53Dep mice at P10 (middle right).
Immunofluorescence staining for ITGB4 (green), cuticle and cortex marker K39 (red), and nuclei (blue) from control,
EgfrDep, and Egfr/p53Dep mice at P10 (far right). Arrows highlight disappearance of layers.
Scale bars, 20 mm unless otherwise stated. See also Figure S4.Loss of EGFR in Adult HFSCs Results in Growth Delay
We next investigated whether EGFR also serves a growth-promoting function in adult HFSCs. Therefore,
we first tested whether EGFR is expressed in adult HFSCs by applying fluorescently labeled epidermal
growth factor to cell suspensions of adult (P45) wild-type mice after completion of the first hair cycle,
when hair is in early telogen. We detected high EGFR expression in CD34+ old and new bulge stem cells,
intermediate expression in IFE, and no expression in CD45+ hematopoietic cells using flow cytometric
analysis (Figure S5A). These results were confirmed by EGFR stainings on back skin sections (Figure S5B).
Furthermore, EGFR expression was detected within the matrix, the ORS and the IRS of anagen HFs (Fig-
ures S5C and S5D). During catagen, scattered EGFR expression was observed in the retracting HF (Fig-
ure S5E). These results suggest that EGFR signaling is required in adult HFSCs. Because it is not possible
to investigate activation and growth of adult HFSCs in EgfrDep mice owing to HF degradation and pro-
gressive hair loss (Lichtenberger et al., 2013), we crossed Egfrfl/fl to Lgr5CreERT2GFP mice to delete the
EGFR after completion of the first postnatal hair cycle (from P43-P47) in lower bulge and secondary hair
germ (2HG) HFSCs by tamoxifen injection (EGFRDLGR5ERT2 mice, Figure S5F). EgfrDLGR5-ERT2 mice were
monitored during progression of the second postnatal hair cycle until P88. EGFR deletion was confirmed
by genomic DNA (Figure S5G) and by immunohistochemistry (IHC) analysis (Figure S5H). EgfrDLGR5-ERT2
mice exhibited delayed entry into the second hair cycle (Figure 6A), demonstrating that EGFR signaling is
involved in HFSC activation and proliferation. This was further underlined by the finding that by the time
of analysis most follicles of control mice had completed the second hair cycle and already returned to
telogen, whereas the majority of HFs of EgfrDLGR5-ERT2 mice was still in anagen of the second cycle (Fig-
ure 6B). Importantly, EgfrDLGR5-ERT2 mice did not display an immune cell infiltrate (Figure 6C), empha-
sizing that the growth delay observed in EgfrDLGR5-ERT2 mice is solely due to cell-autonomous defects
in HFSCs.
To identify molecules deregulated in adult HFSCs upon loss of EGFR, we performed flow cytometric cell
sorting of LGR5+ cells from P88 control and EgfrDLGR5-ERT2 mice and subjected them to RNA-seq (Figures
S5I and S5J). We found 145 genes to be significantly differentially expressed between LGR5+ cells derived
from control and EgfrDLGR5-ERT2 mice (Figures 6D and 6E, Table S2A). Among the differentially expressed
genes, we found genes encoding for structural proteins that were deregulated in our dataset obtained
from P2 EgfrDep mice such as Gjb4 and Klk7 and also genes encoding for signaling and growth molecules
such asWnt3a or Bmp7 indicating that lack of EGFR signaling in LGR5+ HFSCs broadly shifts the balance of
molecules regulating HFSC behavior. Overall, affected genes show enrichment for GO terms such as
‘‘cellular response to chemical stimulus,’’ ‘‘tissue development,’’ ‘‘molting cycle,’’ or ‘‘growth’’ (Figures
6F and 6G, Tables S2B and S2C). Thus loss of EGFR negatively alters the susceptibility of HFSCs to respond
to activating cues (Figure 6H).
Investigation of receptor and ligand expression in control LGR5+ HFSCs revealed that similar to P2 IFE
and ORS, these cells highly express Egfr, Erbb2, and Erbb3, but not Erbb4. Moreover, LGR5+ HFSCs
display low expression of the ligands Tgfa, Epgn, and Hb-egf, whereas all other ligands are not ex-
pressed (Figure S5K).
Furthermore, exons or junction sites of more than 300 genes were affected by alternative splicing alter-
ations in LGR5+ cells of Lgr5+ EgfrDLGR5-ERT2 mice, enriching for GO terms associated with cell stimulation
and intracellular metabolic processes (Figure S5L, Table S2D). Notably, we detected a substantial overlap
of alternative transcripts from 213 genes (10.3%) between P2 IFE + ORS and P88 LGR5+ cells (Figure S5M,
Table S2E), leading to the assumption that EGFR has some identical targets in distinct epidermal compart-
ments at different time points, as well as a variety of specific targets depending on epidermal cell identity
and age. Shared target genes display significant enrichment for GO terms such as ‘‘organelle,’’ ‘‘intracel-
lular signal transduction,’’ and ‘‘cell cycle’’ (Figure S5N, Table S2F), further underlining that EGFR is
required for proliferation and proper orchestration of molecules and pathways involved in both HF devel-
opment and adult HFSC activation and new HF growth.iScience 15, 243–256, May 31, 2019 251
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Figure 5. EGFR Controls Hair Lineage Transcription Factor Expression
(A) IHC staining of GATA-3 from P10 control and EgfrDep mice.
(B) Immunofluorescence staining for P-Cadherin (green), LEF1 (red), and nuclei (blue) from P10 control and EgfrDep mice.
Arrowheads point to hair shaft cells.
(C) Immunofluorescence staining for ITGB4 (green), IRS andmedulla marker AE15 (red), and nuclei (blue) from control and
EgfrDep mice at P10. Arrowheads point on medulla cells.
(D) Model summarizing TP53-dependent mechanisms of cell death in IFE, ORS, and medulla during the growth phase of
HF morphogenesis in EgfrDep mice.
(E) Model summarizing TP53-independent effects of EGFR deficiency in epithelial hair lineages.
Scale bars, 20 mm unless otherwise stated.DISCUSSION
Our study demonstrates that the phenotype of EGFR-deficient skin is multifactorial, displaying alterations
in expression of structural proteins, DNA integrity and DNA damage, proliferation, and apoptosis, but not
stem cell identity genes. Lack of EGFR in newborn skin reduces proliferation in ORS and also in IFE kera-
tinocytes. Analysis of RNA-seq data and subsequent histological analysis demonstrate reduced ERK acti-
vation and loss of expression of the ERK downstream target Egr1 (Mayer et al., 2009; Tarcic et al., 2011) in
EGFR-deficient ORS. In various studies on cancer cells and in mouse models of ERBB2 overexpression a
prominent function of EGFR signaling in promoting keratinocyte proliferation via ERK phosphorylation
has been shown (Lichtenberger et al., 2010) (Bol et al., 1998; Xie et al., 1999; Kiguchi et al., 2000). The pro-
liferation-promoting function of EGFR was mainly assessed in a hyperproliferative context of tumor cells,
whereas only little information is available in the framework of epidermal morphogenesis and homeostasis.
Albeit a reduction of proliferating keratinocytes was shown for the IFE of Egfr/mice (Hansen et al., 1997),
this was never formally shown for the ORS. Importantly, previous studies investigating adult EGFR-deficient
mice could not show changes in pERK by using in vitro assays (Nagao et al., 2012) or in vivo analysis (Wolf
et al., 2016). The absence of effects on pERK levels might be due to assessment of fully developed adult252 iScience 15, 243–256, May 31, 2019
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Figure 6. Loss of EGFR in Adult HFSCs Results in Growth Delay
(A) Photographs of shaved back skin from control and EgfrDLGR5 mice before and during anagen of second hair cycle.
(B) Quantification of percentage of anagen HFs in mice of indicated genotypes at P88. Bars show analysis of 10 hair
follicles per mouse from n = 7–8 mice per genotype. Data are represented as mean G SD. p values less than 0.05 were
considered significant, with ***p < 0.001 as determined by Student’s t test.
(C) Quantification of CD45+ cells in P88 control and EgfrDLGR5mice. Bars show analysis of n = 3–5 mice per genotype. Data
are represented as meanG SD. p values less than 0.05 were considered significant. The data sets do not show staticstical
significance as determined by Student’s t test.
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Figure 6. Continued
(D) Heatmap of significantly deregulated genes between P88 control and EgfrDLGR5 mice. Each column represents one
mouse.
(E) Graphical representation of qRT-PCR validation of randomly selected target genes from LGR5+ cells of P88 control and
EgfrDLGR5 mice. Bars show analysis of n = 4 mice per genotype. Data are represented as mean G SD. p values less than
0.05 were considered significant, with *p < 0.05, **p < 0.01 as determined by Student’s t test.
(F) Bar diagram of GO terms of significantly deregulated genes.
(G) Heatmap of deregulated genes belonging to GO Term ‘‘growth.’’ Each column represents one mouse.
(H) Model depicting the effects of EGFR in adult HFSCs.
See also Figure S5 and Tables S2A–S2F.murine skin, and not neonatal mice, undergoing epidermal morphogenesis. In addition, many other path-
ways have been shown to induce ERK phosphorylation in keratinocytes. Thus our data provide new insight
into a growth-promoting function of EGFR in the developing ORS.
We assessed the specification of committed HFSC populations during early HF development by using
markers LHX2, NFATc1, and NPNT. All factors were equally expressed and localized in control and EgfrDep
mice. Among the group of epidermal structural genes displaying differential gene expression in our RNA-
seq dataset were factors that each alone can result in severe epidermal or hair alterations: mutations in Flg
are known to be involved in the development of atopic dermatitis (Tholen et al., 2016), mutations in Spink5
are reported to cause Netherton syndrome (Raghunath et al., 2004), and mutations in Gjb4 are associated
with erythrokeratodermia variabilis (Richard et al., 2003). These findings demonstrate that one critical role
of EGFR signaling is transcriptional regulation of structural genes directly involved in epidermal
differentiation.
We identified centrosome assembly and function as a novel downstream process of EGFR signaling by our
expression and alternative splicing analysis. IFE keratinocytes lacking EGFR display centrosome amplifica-
tions. Functional consequences of abnormal centrosome numbers due to a disbalance in centrosomal
proteins were previously shown to correlate with genome instability (Vitre and Cleveland, 2012; Nam
et al., 2015). Importantly, defects in centrosome or mitotic spindle assembly leading to the generation
of multiple nuclei are partially causative for the rare disease trichothiodystrophy (Nakabayashi et al.,
2005; Zhang et al., 2007), which affects DNA repair and hair structure.
Generally, genome instability and nuclear fragmentation are accompanied by DNA damage. In the
epidermis, centrosome amplifications result in impaired mitosis and TP53-mediated cell death (Kulukian
et al., 2015). In our datasets, we find transcriptional upregulation of genes associated with cellular response
to DNA damage in EgfrDep mice: TP53 apoptosis effector Perp is known as an apoptosis-associated target
of TP53, involved in its stabilization (Attardi et al., 2000; Davies et al., 2011), and Hmgn2 was reported to
facilitate chromatin accessibility for DNA repair machinery (Subramanian et al., 2009). So far, cross talk be-
tween EGFR and TP53 signaling was only shown in vitro (Kryeziu et al., 2013). Importantly, our data for the
first time provide in vivo evidence for a role of EGFR signaling in prevention of DNA damage in proliferating
cells and for susceptibility of epidermal cells to TP53-mediated apoptosis upon loss of EGFR. Despite the
DNA-damage-induced apoptosis in proliferative keratinocyte compartments, we detect TP53-indepen-
dent cell loss in differentiated epithelial hair layers comprising the hair shaft. Suprabasal-transit-amplifying
cells, which give rise to those innermost hair layers, display a requirement for EGFR signaling to induce cor-
rect transcription factor expression of the lineage diversification factor Lef1. During morphogenesis, LEF1
protein is not detectable in hair shaft cells of EGFR-deficient epidermis, thus presumably reducing the
expression of hair-shaft-specific genes. These defects ultimately lead to loss of hair shaft cells, hair
structure alteration, and hair malformation.
Limitation of the Study
We are formally not able to discriminate between a cell-autonomous function of EGFR in epithelial hair line-
age differentiation, or a secondary effect on hair shaft differentiation following absence of EGFR in all
epithelial skin lineages. To date, there are no-hair shaft-specific Cre lines available that would allow
detailed investigation of the effects of Egfr deletion in these particular hair lineages.
METHODS
All methods can be found in the accompanying Transparent Methods supplemental file.254 iScience 15, 243–256, May 31, 2019
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Figure S1. Loss of EGFR results in hair alterations. Related to Figure 1 
(A)  Schematic picture of Egfr ∆ep mice.  
(B)  Immunohistochemistry staining of EGFR on sections of an E16.5 control and Egfr ∆ep mouse.  
(C)  Brightfield images of plucked hair from P22 control and Egfr ∆ep mice.  
Scale bars 20µm unless otherwise stated.  
 
Fig. S2, Amberg et al
A B
C
FSC FSC FSC FSC FSC
H
oe
ch
st
C
D
45
α6
 In
te
gr
in
Sc
a-
I
LG
R
5:
G
FP
Egfr promoter + exon1
K5-Cre
LGR5-IRES-EGFP CreERT2
epidermal 
suspension
FACS based
cell sorting
IFE: α6hi Sca-Ihi
ORS: LGR5:GFP+
6.97
32.1
29.3
3.74
96.037.4
RNAseq
RNAseq
0
1
2
3
4
5
6
%
 o
f l
iv
e 
ce
lls
E
%
 o
f L
G
R
5+
 c
el
ls
0
10
20
30
40
0
20
40
60
80
100
F G
*** *** EgfrΔep
Egfrfl/fl
H
Egfrfl/fl EgfrΔep
P2
LGR5:GFP β4
P2
D
0
1
2
3
4
LGR5hi cellsLGR5lo cellsLGR5+ cells
%
 o
f L
G
R
5+
 c
el
ls
CD45+ cells
%
 o
f l
iv
e 
ce
lls
EgfrΔep LGR5-EGFP-CreERT2 
LGR5hi
LGR5lo
Erbb2
Tgfa
Nrg2
Egfr
Erbb3
Epgn
Areg
Nrg3
Erbb4
Ereg
Egf
Nrg4
Hbegf
Btc
Nrg1
−4
−2
0
2
4
6
IFE ORS
I
Figure S2. Flow cytometric analysis of newborn mouse skin. Related to Figure 2 
(A)  Schematic picture of Egfr ∆ep LGR5-CreERT2GFP mice.  
(B)  Schematic overview of work flow for RNAseq.  
(C)  FACS gating strategy for cell sorting of IFE and ORS cells from P2 control and Egfr ∆ep LGR5-CreERT2GFP 
mice.  
(D) Quantification of CD45+ cells, (E) all LGR5:EGFP+ cells, (F) LGR5:EGFPlo cells, and (G) LGR5:EGFPhi 
cells as from FACS analysis of epidermal cell suspensions of P2 control and Egfr ∆ep LGR5-CreERT2GFP 
mice. Bars show data from n = 4-5 mice per genotype. Statistical significance was determined by Student’s 
t-test with p < 0.5 *, p < 0.01 **, p < 0.005 ***.  
(H) Immunofluorescence staining for GFP (green), ITGB4 (red) and nuclei (blue) from P2 control and Egfr ∆ep 
LGR5-CreERT2GFP mice, showing HF. 
(I) Heat map showing expression of Erbb receptors and their ligands in control samples from P2 IFE and P2 ORS. 
Each column represents one mouse. 
Scale bars 20µm unless otherwise stated.  
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Figure S3. Confirmatory experiments on functional relevance of RNAseq analysis. Related to Figure 3 
(A)  Immunofluorescence staining for BrdU (green) 24h after pulsing.  
(B)  Immunofluorescence stainings for ITGB4 Integrin (green), Ki67 (red), and nuclei (blue) from control and 
Egfr ∆ep mice at indicated timepoints, showing IFE.  
(C)  JunctionSeq diagram of exon and junction site usage within the Cntrl gene (top). Purple coloured exons and 
junction sites show significantly differentially used elements. Schematic drawing of protein domains of Cntrl 
(bottom).  
(D)  JunctionSeq diagram of exon and junction site usage within the Clspn gene (top). Purple coloured exons and 
junction sites show significantly differentially used elements. Schematic drawing of protein domains of Clspn 
(bottom).   
(E)  Immunofluorescence staining for K14 (green), K1 (red) and nuclei (blue) of primary keratinocytes. Bars 
10µm.  
Scale bars 20µm unless otherwise stated.  
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Figure S4. Additional deletion of TP53 does not rescue survival and hair phenotype of mice with EGFR-
deficient epidermis. Related to Figure 4 
(A)  Schematic representation of genetics of Egfr/p53∆ep mice.  
(B)  Agarose gel image of p53 Δallele-specific PCR from control and Egfr/p53∆ep mice.  
(C)  Photographs of P19 control, Egfr ∆ep and Egfr/p53∆ep mice.  
(D)  Survival curves of control, Egfr ∆ep and Egfr/p53∆ep mice. Each line shows data from n = 15 mice per 
genotype. 
(E)  Immunofluorescence staining of back skin sections for CD45 (green), K5 (red) and nuclei (blue) of P19 
control, Egfr ∆ep and Egfr/p53∆ep mice.  
Scale bars 50µm.  
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Figure S5. Analysis of localization and function of EGFR in the epidermis of adult mice. Related to Figure 6 
(A)  Histogram from FACS analysis of P45 mice showing intensity of EGF-A647 for indicated epidermal 
compartments.  
(B)  Immunohistochemistry staining of EGFR on a back skin section of an adult control mouse. IFE – 
interfollicular epidermis; Inf – Infundibulum; SG – sebaceous gland; Bu – bulge; 2°HG – secondary hair 
germ; DP – dermal papilla. 
(C)  Immunohistochemistry staining of EGFR on a back skin section of an adult control mouse, showing the 
matrix of an anagen HF. 
(D)  Immunohistochemistry staining of EGFR on a back skin section of an adult control mouse, showing the hair 
shaft of an anagen HF; ORS – outer root sheath; Me – medulla; IRS – inner root sheath. 
(E)  Immunohistochemistry staining of EGFR on a back skin section of an adult control mouse, showing a 
catagen HF.  
(F)  Schematic representation of genetics of Egfr∆LGR5 mice and treatment regimen.  
(G)   Agarose gel image of Egfr Δ-allele specific PCR from back skin of control and Egfr∆LGR5 mice.  
(H)  Immunohistochemistry staining of back skin sections of P88 control and Egfr∆LGR5 mice, showing anagen 
and telogen HFs. 
(I) Schematic overview of work flow for RNAseq.  
(J) FACS gating strategy for cell sorting of LGR5+ cells from P88 control and Egfr∆LGR5 mice.  
(K) Heat map showing expression of Erbb receptors and their ligands from control samples of P88 LGR5+ 
HFSCs. Each column represents one mouse.  
(L)  Bar diagram of top 15 GO terms of alternatively used exons and junction sites of LGR5+ cells from P88 
Egfr∆LGR5 mice.  
(M)  Venn diagram of alternatively spliced genes from P2 IFE + ORS and P88 LGR5+ cells.  
(N)  Bar diagram of GO terms of shared alternatively spliced genes between P2 IFE + ORS and P88 LGR5+ cells.  
Scale bars 20µm unless otherwise stated.  
 
Transparent Methods 
Mice  
Mice were kept in the animal facilities of the Medical University of Vienna in accordance with institutional policies 
and federal guidelines. Animal experiments were approved by the Animal Experimental Ethics Committee of the 
Medical University of Vienna and the Austrian Federal Ministry of Science and Research (animal license numbers: 
GZ 66.009/124-BrGT/2003; GZ 66.009/109-BrGT/2003; BMWF-66.009/0073-II/10b/2010; BMWF-66.009/0074-
II/10b/2010). EGFRfl/fl mice (Natarajan et al. 2007) were kept in C57BL/6 background for more than 30 generations 
and were crossed with K5Cre transgenic mice (Tarutani et al. 1997), (LGR5-EGFP-CreERT2 knock-in mice (Barker et 
al. 2007) and p53fl/fl mice (Marino et al. 2000). While K5Cre and LGR5-EGFP-CreERT2 mice were of C57BL/6 
background, p53fl/fl mice were of mixed background. Sequences of genotyping primers can be found in Supplemental 
Table S2.  
No phenotypic differences have been identified between male and female mice, thus all experiments were conducted 
using both genders. Age of analysed mice is indicated in each figure legend.  
Embryonic and newborn pups were sacrificed by decapitation. Mice older than P3 were sacrificed by cervical 
dislocation.  
For Tamoxifen-induced deletion of EGFR, 1mg TamoxifenImouse (resolved in 10v/v% EtOH (Roth) and 90v/v% sun 
flower seed oil (Sigma) was injected for 5 consecutive days from P43-47.  
 
Keratinocyte culture 
Back skin was surgically removed and subcutaneous adipose tissue was gently removed. Skin was placed dermal-side 
down on 0.8% Trypsin (diluted in PBS, Sigma) at 37°C for 30min. Epidermis was peeled off under a sterile laminar 
flow hood, transferred to a 1.5ml Eppendorf tube containing PBS + 2% chelated FCS and chopped into tiny pieces 
using sterile scissors. This solution was transferred to 15ml Falcon tube and after adding 5ml DNaseI solution (Sigma, 
#DN25, 250µg/ml in MEM + 8% chelated FCS) incubated on a rotating shaker at 37°C for 45min. 10ml PBS + 2% 
chelated FCS were added and the solution was pipetted up and down several times and passed over a 70µm cell strainer 
into a new tube. After centrifugation at 300g for 10min, cells were resuspended in keratinocyte medium (PromoCell, 
medium constituted according to the manufacturer’s instructions), counted and incubated at a concentration of 5x104 
cells/well in pre-coated 8-well chamber slides at 32°C (Coating medium: 100ml MEM, 10ml BSA (FractionV 
1mg/ml), 1ml 2mM HEPES pH 7.3, 1ml PureCol (Inamed BioMaterials), 1ml 1mg/ml Fibronectin, 1.16ml 100mM 
CaCl2). 24-36 hours later, medium was changed and cells were allowed to grow for 2-3 more days.     
 
BrdU incorporation assay  
For in vivo ORS BrdU incorporation assays, newborn mice were injected with 0.625mg BrdU once and sacrificed 24h 
later. For IFE BrdU incorporation assays, mice of 5, 8, or 10 days of age were injected with BrdU and sacrificed 4h 
later.  
 
Histology (Sections)  
For histological analysis, skin was processed as described previously (Amberg et al. 2015). Briefly, paraffin-embedded 
skin biopsies were cut into 4μm thin sections and stained with Hematoxylin & Eosin or Fontana Masson according to 
standard protocols or subjected to immunohistochemistry (IHC) stainings. For IHC, samples were deparaffinized and 
rehydrated, antigen retrieval was performed using the respective antigen retrieval buffer and an aptum Retriever 2100 
antigen retrieval machine. Endogenous peroxidase was blocked by incubation in 3% H2O2 in Methanol for 10min, 
followed by biotin blocking using Endogenous Biotin Blocking Kit (LifeTech) for 20min each and blocking of 
unspecific antibody binding using PBS supplemented with 1% BSA, 5% Horse Serum and 0.1% Triton X-100 for 1h 
at room temperature before adding primary antibodies. In case primary antibodies were raised in mouse, blocking was 
performed using M.O.M. kit (mouse on mouse, Vector Laboratories, FKM-2201). Primary antibodies were incubated 
in antibody blocking buffer (1% BSA, 5% Horse Serum, 0.1% TritonX-100 in PBS) over night at 4°C. Biotinylated 
secondary antibodies were diluted 1:500 in antibody blocking buffer and incubated at room temperature for 1h, 
followed by Streptavidin incubation for 30min. After DAB reaction was performed, sections were counterstained with 
Gill's Hematoxylin, dehydrated and embedded using Entellan.  
For BrdU stainings, 4μm paraffin sections were incubated with 1N HCI at 37°C for 1h, blocked with antibody blocking 
buffer and stained with anti-BrdU antibody (BD, 1:50) at 4°C over night. Secondary antibody was diluted 1:500 in 
blocking buffer, and together with Hoechst (1μg/ml) incubated for 1h at room temperature, before mounting with 
DAKO mounting medium.  
 
In order to obtain frozen samples, skin biopsies were embedded in Sakura O.C.T., frozen on dry ice and stored at -
80°C until sectioning in a Histocom cryomicrotome. 6μm sections were stored at -80°C until further use. For GFP 
staining, fresh skin biopsies were fixed in 4% PFA for 2h and incubated in 30% sucrose in PBS at 4°C over night prior 
to embedding and freezing in Sakura O.C.T. Frozen sections were thawed, blocked with 4% PFA for 10min at room 
temperature, incubated with antibody blocking buffer for 1h at room temperature and stained with primary antibody 
diluted in antibody blocking buffer at 4°C over night. Secondary antibodies were diluted 1:500 in blocking buffer, and 
together with Hoechst (1μg/ml) incubated for 1h at room temperature, before mounting with DAKO mounting 
medium.  
 
Sections were all imaged at a Nikon Eclipse i80 microscope using NIS Elements software (equipped with a Nikon 
DS-U2 camera for brightfield microscopy and a Nikon DS-Qi2 camera for epifluorescence microscopy), a Zeiss Axio 
lmager using Axio Vision software or a Zeiss LSM700 confocal microscope using ZEN2010. Images were further 
processed using Photoshop5.  
 
Histology (Transmission electron microscopy)  
Back skin biopsies were cut into pieces of 1x1 mm, fixed in 3% glutaraldehyde (AGAR Scientific) in 0.1M caco 
buffer (AGAR Scientific), post-fixed in 1 % osmium tetroxide (EMS), dehydrated and embedded in Agar Low 
Viscosity resin (AGAR Scientific). 80nm ultrathin sections were performed at a Reichert-Jung Ultracut E microtome 
and stored on copper grids (AGAR Scientific).Sections were further stained in 0.5% uranyl acetate (Laurylab) and 3% 
lead citrate (Laurylab) before imaging at a TEM Philips I FEI EM 208 or a TEM ZEISS EM 902.  
Histology (primary keratinocytes)  
Medium was removed and cells were washed with PBS 3 times. Cells were incubated with 4% PFA for 30min at RT, 
washed with PBS 3 times and staining procedure was identical to histological sections. Phalloidin-A488 was diluted 
1:1000. Images were acquired at a Zeiss LSM700 confocal microscope, using ZEN2010 software.  
 
Flow cytometry  
Epidermal cell suspensions were generated by surgically removing the trunk skin and gently scraping off subcutaneous 
adipose tissue. Skin was then placed on DMEM (Gibco) containing 2mM EDTA and 0.25% Trypsin (Gibco) at 4°C 
over night. Next day, epidermis was softly scraped off and further dissociated into single cells by pipetting up and 
down after adding DMEM containing 2% chelexed FCS (Sigma). Cells were filtered using 70μm and 40μm cell 
strainers (BD), centrifuged at 300g for 10min, and washed with PBS (Sigma) containing 2% chelexed FCS twice 
before staining. Epidermal single cell suspensions were incubated with the following antibodies: a6-PE (BD, 1:50), 
Scal-PECy7 (Biolegend, 1:100), CD45-APCCy7 (BD, 1:200), CD34-biotinylated (eBioscience, 1:50), Streptavidin-
APC or Streptavidin-A700 (BD or LifeTech, 1:400). A647-labelled EGF was purchased from LifeTechnologies and 
incubated in a dilution of 1:20 for 30min on ice in an additional step after antibody staining. Dead cell exclusion was 
performed using Hoechst (1μg/ml). BrdU analysis was performed according to the manufacturer’s instructions (BD 
APC BrdU Flow Kit, Cat# 552598). For evaluation of BrdU+ cell numbers and intensity measurement of EGF-A647, 
a BD Fortessa cytometer with BD FACSDiva software was used. Further analysis was conducted using FlowJo 
(Trestar) software. Cell sorting of IFE and ORS cell populations from P2 skin, as well as of P88 LGR5+ HFSCs was 
performed using a BD AriaI and BD FACSDiva software. 
 
RNA isolation  
Approx. 8,000 IFE and 1,000 LGR5+ keratinocytes were sorted into RNA Extraction Buffer of the PicoPure RNA 
Isolation Kit (Arcturus), incubated at 42°C for 30min and centrifuged at 800g for 2 min. Supernatants were transferred 
into new tubes and stored at -80°C until further RNA purification according to the manufacturer's instructions, despite 
the last step. For RNA elution, we did not use the provided Elution Buffer, but RNase-free water in order to be able 
to measure RNA quality with the BioAnalyzer (Total Eukaryote RNA Pico Kit, Agilent, according to the 
manufacturer’s instructions). 
 
Library Preparation  
RNA samples with RIN > 8.0 were used for RNAsequencing. Libraries were prepared using SMARTer Ultra Kit 
(Clontech, #63482) and Low Input Library Prep Kit (Clontech, #634947) according to the manufacturer’s instructions. 
Libraries were subjected to paired-end 150bp read RNAseq at the Biomedical Sequencing facility of the CEMM 
(Vienna, Austria) using the HiSeq2500 (Illumina Inc.).   
 
RNAseq analysis  
TopHat2 algorithm was used to align raw RNA-seq data to mm10 (Kim et al. 2013). Differentially expressed genes 
were identified using DeSeq2 algorithm (Love et al. 2014). An adjusted P<0.1 was defined as cutoff for differentially 
expressed genes. Gene Ontology analyses were performed using Ontologizer software (Bauer et al. 2008). Differential 
splicing was analyzed using the R package JunctionSeq (Hartley and Mullikin 2016).  
 
Data availability  
Raw data from RNAseq experiments are available at the NCBI Gene Expression Omnibus (GEO) with the GEO 
accession number GSE128436.  
 
qRT-PCR 
cDNA was generated using VILO cDNA synthesis kit (Life Technologies) according to the manufacturer’s protocol. 
cDNA was stored at -20°C until further use. qRT-PCR was run with SYBR green (Peqlab) on an ABI7500 qRT-PCR 
machine under the following conditions: an initial incubation at 50°C for 20sec and 95°C for 10 min followed by 40 
cycles of 95°C for 15sec, 54°C for 1 min. Relative quantification of RNA was calculated by the ΔΔCt method using 
Gapdh as reference gene. Primer sequences were purchased from MWG Eurofins.  
 
Statistics  
Data were analysed by two-tailed Student's t test, Kruskal-Wallis test or multiple t-tests according to Two-stage linear 
step-up procedure of Benjamini, Krieger and Yekutieli with Q = 1%. Error bars represent ±SD. Exact number of 
animals and samples are stated in the figure legends. P values less than 0.05 were considered significant, with p< 0.05 
*, p < 0.01 **, p < 0.001 ***.  
 
Polar Plots  
Polar plots were generated using R software.  
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